Form D · Pharmaceuticals
SiO2 Medical Products, Inc.
Auburn, AL · CIK 0001743644
Offering snapshot reported Oct 4, 2019 · SEC filing
- Reported sold
- $48M Offering amount: $60M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 4, 2019 | Initial | $48,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350380
Source: Form D, filed Oct 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert S. Abrams | Director, Executive |
| John Belfance | Director |
| Helmut Jeggle | Director |
| Jared Morris | Director |
| Jean Marie Painvin | Director |
| Robert Pangborn | Director |
| Anthony Rosenberg | Director |
| Melissa Simon | Director |
| John Stein | Director |
| Thomas Strungmann | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2250 Riley Street
Auburn, AL, 36832
Auburn, AL, 36832